Clinical efficacy and safety of a beta3-adrenoceptor agonist (mirabegron) and an antimuscarinic agent (imidafenacin) in female patients with overactive bladder: a randomized crossover study

Research Type

Clinical

Abstract Category

Overactive Bladder

Links
	Abstract 487
	Pharmacotherapy for Overactive Bladder Scientific Podium Short Oral Session 34
	Friday 9th October 2015
	09:00 - 09:07
	515ABC
	Clinical Trial Female Overactive Bladder Pharmacology Prospective Study
	1. Nara Medical University, 2. Tane General Hospital, 3. Hirao Hospital, 4. Hoshigaoka Medical Center, 5. Nara Hospital Kinki University Faculty of Medicine
Presenter
K Kazumasa Torimoto
Abstract PDF Disclosure PDF Edit Abstract Abstract Centre